A |
2024-06-12 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
6820.0000 |
36431.0000 |
1 |
0000882796 |
Common Stock |
A |
2024-06-12 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
49933.0000 |
49933.0000 |
2 |
0000882796 |
Automatic Stock Option Grant |
A |
2023-06-13 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
16745.0000 |
29611.0000 |
1 |
0000882796 |
Common Stock |
A |
2023-06-13 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
39072.0000 |
39072.0000 |
2 |
0000882796 |
Automatic Stock Option Grant |
A |
2022-06-07 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
12866.0000 |
12866.0000 |
1 |
0000882796 |
Common Stock |
A |
2022-06-07 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
30022.0000 |
30022.0000 |
2 |
0000882796 |
Automatic Stock Option Grant |
A |
2022-04-18 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
5000.0000 |
5000.0000 |
1 |
0000882796 |
Common Stock |
D |
2022-04-18 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
S-Sale |
--D |
5000.0000 |
0.0000 |
2 |
0000882796 |
Common Stock |
D |
2022-04-18 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
5000.0000 |
0.0000 |
3 |
0000882796 |
Automatic Stock Option Grant |
A |
2022-02-15 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
5000.0000 |
5000.0000 |
1 |
0000882796 |
Common Stock |
D |
2022-02-15 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
S-Sale |
--D |
5000.0000 |
0.0000 |
2 |
0000882796 |
Common Stock |
D |
2022-02-15 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
5000.0000 |
5000.0000 |
3 |
0000882796 |
Automatic Stock Option Grant |
A |
2021-11-15 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
5000.0000 |
5000.0000 |
1 |
0000882796 |
Common Stock |
D |
2021-11-15 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
S-Sale |
--D |
5000.0000 |
0.0000 |
2 |
0000882796 |
Common Stock |
D |
2021-11-15 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
5000.0000 |
10000.0000 |
3 |
0000882796 |
Automatic Stock Option Grant |
A |
2021-09-15 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
5000.0000 |
5000.0000 |
1 |
0000882796 |
Common Stock |
D |
2021-09-15 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
S-Sale |
--D |
5000.0000 |
0.0000 |
2 |
0000882796 |
Common Stock |
D |
2021-09-15 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
5000.0000 |
0.0000 |
3 |
0000882796 |
Non-Qualified Stock Option |
A |
2021-09-10 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
11000.0000 |
14000.0000 |
1 |
0000882796 |
Common Stock |
A |
2021-09-10 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
30000.0000 |
44000.0000 |
2 |
0000882796 |
Common Stock |
A |
2021-09-10 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
30000.0000 |
74000.0000 |
3 |
0000882796 |
Common Stock |
D |
2021-09-10 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
S-Sale |
--D |
74000.0000 |
0.0000 |
4 |
0000882796 |
Common Stock |
D |
2021-09-10 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
11000.0000 |
0.0000 |
5 |
0000882796 |
Automatic Stock Option Grant |
D |
2021-09-10 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
30000.0000 |
0.0000 |
6 |
0000882796 |
Automatic Stock Option Grant |
D |
2021-09-10 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
30000.0000 |
0.0000 |
7 |
0000882796 |
Automatic Stock Option Grant |
A |
2021-07-15 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
5000.0000 |
8000.0000 |
1 |
0000882796 |
Common Stock |
D |
2021-07-15 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
S-Sale |
--D |
5000.0000 |
3000.0000 |
2 |
0000882796 |
Common Stock |
D |
2021-07-15 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
5000.0000 |
5000.0000 |
3 |
0000882796 |
Non-Qualified Stock Option |
A |
2021-05-25 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
40000.0000 |
40000.0000 |
1 |
0000882796 |
Automatic Stock Option Grant |
A |
2021-05-24 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
6667.0000 |
9667.0000 |
1 |
0000882796 |
Common Stock |
D |
2021-05-24 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
S-Sale |
--D |
6667.0000 |
3000.0000 |
2 |
0000882796 |
Common Stock |
D |
2021-05-24 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
6667.0000 |
10000.0000 |
3 |
0000882796 |
Non-Qualified Stock Option |
D |
2021-05-10 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
S-Sale |
--D |
7000.0000 |
3000.0000 |
1 |
0000882796 |
Common Stock |
A |
2020-05-12 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
40000.0000 |
40000.0000 |
1 |
0000882796 |
Automatic Stock Option Grant |
A |
2020-02-14 |
|
Brickell Biotech, Inc. |
4 |
A-Award |
--D |
2167.0000 |
2167.0000 |
12 |
0000819050 |
Restricted Stock Units |
A |
2020-02-14 |
|
Brickell Biotech, Inc. |
4 |
A-Award |
--D |
8764.0000 |
8764.0000 |
13 |
0000819050 |
Stock Options |
A |
2019-05-29 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
30000.0000 |
30000.0000 |
1 |
0000882796 |
Automatic Stock Option Grant |
D |
2018-08-21 |
|
Innoviva, Inc. |
4 |
S-Sale |
--D |
8000.0000 |
285479.0000 |
2 |
0001080014 |
Common Stock |
D |
2018-08-20 |
|
Innoviva, Inc. |
4 |
F-InKind |
--D |
5680.0000 |
293479.0000 |
1 |
0001080014 |
Common Stock |
A |
2018-06-20 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
30000.0000 |
30000.0000 |
1 |
0000882796 |
Automatic Stock Option Grant |
D |
2018-05-21 |
|
Innoviva, Inc. |
4 |
S-Sale |
--D |
8000.0000 |
299159.0000 |
2 |
0001080014 |
Common Stock |
D |
2018-05-20 |
|
Innoviva, Inc. |
4 |
F-InKind |
--D |
4682.0000 |
305235.0000 |
1 |
0001080014 |
Common Stock |
A |
2018-03-02 |
|
Innoviva, Inc. |
4 |
A-Award |
--D |
74444.0000 |
309917.0000 |
1 |
0001080014 |
Common Stock |
D |
2018-02-21 |
|
Innoviva, Inc. |
4 |
S-Sale |
--D |
8000.0000 |
235473.0000 |
2 |
0001080014 |
Common Stock |
D |
2018-02-20 |
|
Innoviva, Inc. |
4 |
F-InKind |
--D |
15500.0000 |
243473.0000 |
1 |
0001080014 |
Common Stock |
D |
2017-11-21 |
|
Innoviva, Inc. |
4 |
S-Sale |
--D |
5215.0000 |
258651.0000 |
2 |
0001080014 |
Common Stock |
D |
2017-11-20 |
|
Innoviva, Inc. |
4 |
F-InKind |
--D |
3358.0000 |
263866.0000 |
1 |
0001080014 |
Common Stock |
D |
2017-08-20 |
|
Innoviva, Inc. |
4 |
F-InKind |
--D |
2886.0000 |
267224.0000 |
1 |
0001080014 |
Common Stock |
A |
2017-05-24 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
30000.0000 |
30000.0000 |
1 |
0000882796 |
Automatic Stock Option Grant |
D |
2017-05-20 |
|
Innoviva, Inc. |
4 |
F-InKind |
--D |
2228.0000 |
270110.0000 |
1 |
0001080014 |
Common Stock |
D |
2017-02-20 |
|
Innoviva, Inc. |
4 |
F-InKind |
--D |
5355.0000 |
269838.0000 |
1 |
0001080014 |
Common Stock |
A |
2017-01-17 |
|
Innoviva, Inc. |
4 |
A-Award |
--D |
106718.0000 |
275193.0000 |
1 |
0001080014 |
Common Stock |
D |
2016-11-20 |
|
Innoviva, Inc. |
4 |
F-InKind |
--D |
1273.0000 |
168475.0000 |
1 |
0001080014 |
Common Stock |
D |
2016-08-20 |
|
Innoviva, Inc. |
4 |
F-InKind |
--D |
1939.0000 |
169463.0000 |
1 |
0001080014 |
Common Stock |
A |
2016-05-23 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
30000.0000 |
30000.0000 |
1 |
0000882796 |
Automatic Stock Option Grant |
D |
2016-05-20 |
|
Innoviva, Inc. |
4 |
F-InKind |
--D |
1276.0000 |
171402.0000 |
1 |
0001080014 |
Common Stock |
D |
2016-02-19 |
|
Innoviva, Inc. |
4 |
F-InKind |
--D |
5376.0000 |
170178.0000 |
1 |
0001080014 |
Common Stock |
A |
2016-01-14 |
|
Innoviva, Inc. |
4 |
A-Award |
--D |
92587.0000 |
175554.0000 |
1 |
0001080014 |
Common Stock |
A |
2015-05-20 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
15000.0000 |
15000.0000 |
1 |
0000882796 |
Automatic Stock Option Grant |
A |
2015-01-07 |
|
THERAVANCE INC |
4 |
A-Award |
--D |
71429.0000 |
81429.0000 |
1 |
0001080014 |
Common Stock |
A |
2014-06-19 |
|
THERAVANCE INC |
4 |
A-Award |
--D |
10000.0000 |
10000.0000 |
1 |
0001080014 |
Common Stock |
A |
2014-06-19 |
|
THERAVANCE INC |
4 |
A-Award |
--D |
100000.0000 |
100000.0000 |
2 |
0001080014 |
Stock Option Grant (Right to Buy) |
A |
2014-05-02 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
15000.0000 |
15000.0000 |
1 |
0000882796 |
Automatic Stock Option Grant |
A |
2014-03-31 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
4000.0000 |
10000.0000 |
1 |
0000882796 |
Common Stock |
D |
2014-03-31 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
4000.0000 |
11000.0000 |
2 |
0000882796 |
Automatic Stock Option Grant |
A |
2013-11-12 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
P-Purchase |
--D |
3000.0000 |
6000.0000 |
1 |
0000882796 |
Common Stock |
A |
2013-05-31 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
15000.0000 |
15000.0000 |
1 |
0000882796 |
Automatic Stock Option Grant |
A |
2013-03-05 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
P-Purchase |
--D |
3000.0000 |
3000.0000 |
1 |
0000882796 |
Common Stock |
A |
2012-08-07 |
|
TRANZYME INC |
4 |
A-Award |
--D |
31835.0000 |
31835.0000 |
1 |
0001274644 |
Stock Option (Right to Buy) |
A |
2012-05-23 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
15000.0000 |
15000.0000 |
1 |
0000882796 |
Automatic Stock Option Grant |
A |
2011-10-18 |
|
TRANZYME INC |
4 |
A-Award |
--D |
25000.0000 |
25000.0000 |
1 |
0001274644 |
Stock Option (Right to Buy) |
A |
2011-10-18 |
|
TRANZYME INC |
4/A |
A-Award |
--D |
25000.0000 |
25000.0000 |
1 |
0001274644 |
Stock Option (Right to Buy) |
A |
2011-10-10 |
|
BIOCRYST PHARMACEUTICALS INC |
4 |
A-Award |
--D |
16667.0000 |
16667.0000 |
1 |
0000882796 |
Non-Qualified Stock Option |
D |
2011-05-13 |
|
INSPIRE PHARMACEUTICALS INC |
4 |
U-Tender |
--D |
1099.0000 |
0.0000 |
1 |
0001040416 |
Common Stock |
D |
2011-05-13 |
|
INSPIRE PHARMACEUTICALS INC |
4 |
D-Return |
--D |
10164.0000 |
0.0000 |
2 |
0001040416 |
Stock Option (Right to Buy) |
D |
2011-05-13 |
|
INSPIRE PHARMACEUTICALS INC |
4 |
D-Return |
--D |
18970.0000 |
0.0000 |
3 |
0001040416 |
Stock Option (Right to Buy) |
D |
2011-05-13 |
|
INSPIRE PHARMACEUTICALS INC |
4 |
D-Return |
--D |
2371.0000 |
0.0000 |
4 |
0001040416 |
Stock Option (Right to Buy) |
D |
2011-05-13 |
|
INSPIRE PHARMACEUTICALS INC |
4 |
D-Return |
--D |
6873.0000 |
0.0000 |
5 |
0001040416 |
Restricted Stock Unit |
D |
2011-05-13 |
|
INSPIRE PHARMACEUTICALS INC |
4 |
D-Return |
--D |
12739.0000 |
0.0000 |
6 |
0001040416 |
Restricted Stock Unit |
A |
2010-06-03 |
|
INSPIRE PHARMACEUTICALS INC |
4 |
M-Exempt |
--D |
1592.0000 |
1592.0000 |
1 |
0001040416 |
Common Stock |